A mass in the pancreatic tail: Follicular dendritic cell sarcoma
Asian J Surg. 2023 Aug 26:S1015-9584(23)01254-X. doi: 10.1016/j.asjsur.2023.08.093. Online ahead of print.NO ABSTRACTPMID:37640645 | DOI:10.1016/j.asjsur.2023.08.093 (Source: Asian Journal of Surgery)
Source: Asian Journal of Surgery - August 28, 2023 Category: Surgery Authors: Zehai Gao Andong Xiang Jing Tang Hanyu Li Source Type: research
A mass in the pancreatic tail: Follicular dendritic cell sarcoma
Asian J Surg. 2023 Aug 26:S1015-9584(23)01254-X. doi: 10.1016/j.asjsur.2023.08.093. Online ahead of print.NO ABSTRACTPMID:37640645 | DOI:10.1016/j.asjsur.2023.08.093 (Source: Asian Journal of Surgery)
Source: Asian Journal of Surgery - August 28, 2023 Category: Surgery Authors: Zehai Gao Andong Xiang Jing Tang Hanyu Li Source Type: research
The role of radiation therapy in the management of primary retroperitoneal sarcoma: a systematic review and clinical practice guidelines from the Australia and New Zealand Sarcoma Association
Retroperitoneal sarcomas (RPS) are rare malignancies that can be difficult to manage given their large and often irregular size, and tendency to involve critical retroperitoneal structures. While surgery is the cornerstone of treatment, the role of radiation therapy (RT) remains controversial, with differences in practice between centres. Some centres recommend preoperative RT if macroscopically complete resection is thought not to be feasible based on preoperative imaging. Other centres do not generally recommend RT, or recommend RT for specific sub-types such as low grade liposarcoma. (Source: Cancer Treatment Reviews)
Source: Cancer Treatment Reviews - August 28, 2023 Category: Cancer & Oncology Authors: Anna Lawless, Deborah Di-Xin Zhou, Joshua McDonough, Helen Lo, Jasmine Mar, Smaro Lazarakis, Iain Ward, Joanna Connor, Stephen R Thompson, David Coker, Andrew Johnston, David E Gyorki, Angela M Hong Tags: Systematic or Meta-analysis Studies Source Type: research
Cancers, Vol. 15, Pages 4306: Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
rançois Le Loarer
Marie Karanian
Carine Ngo
Simone Mathoulin Pélissier
Carine Bellera
Axel Le Cesne
Jean Yves Blay
Antoine Italiano
Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors characterized by KIT or PDGFRA mutations. Over three decades, significant changes in drug discovery and loco-regional (LR) procedures have impacted treatment strategies. We assessed the evolution of treatment strategies for metastatic GIST patients treated in the three national coordinating centers of NetSarc, the French network of sarcoma referral centers endorsed by the National Institute of Cancers, from ...
Source: Cancers - August 28, 2023 Category: Cancer & Oncology Authors: Maud Toulmonde Derek Dinart Mehdi Brahmi Benjamin Verret Myriam Jean-Denis Fran çoise Ducimetière Gregoire Desolneux Pierre M éeus Jean Palussi ère Xavier Buy Amine Bouhamama Pauline Gillon Armelle Dufresne Cl émence Hénon Fran çois Le Loarer Marie Tags: Article Source Type: research
Clinical perspectives and outcomes of the giant breast phyllodes tumor and sarcoma: a real-world retrospective study
Giant breast malignant phyllodes tumor or sarcoma (GBPS) are rare entities with diameter larger than 10 cm and variously histological pleomorphisms. This disease poses a significant threat to the quality of li... (Source: BMC Cancer)
Source: BMC Cancer - August 28, 2023 Category: Cancer & Oncology Authors: Naiquan Liu, Ye Kang, Ningxin Qu, Chenhui Kong and Ye Han Tags: Research Source Type: research
Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo
In conclusion, we demonstrated that tazemetostat is a unique multispecific chemosensitizer, which has strong potential to overcome limitations seen in the era of traditional MDR modulators.PMID:37634597 | DOI:10.1016/j.bcp.2023.115769 (Source: Biochemical Pharmacology)
Source: Biochemical Pharmacology - August 27, 2023 Category: Drugs & Pharmacology Authors: Youssif Budagaga Ziba Sabet Yu Zhang Eva Novotn á Ivo Hanke Tom áš Rozkoš Jakub Hofman Source Type: research
Pulmonary histiocytic sarcoma
We report the case of a 52-year-old man with a tumor of central localization in the left lung. Pulmonectomy was performed. Histology verified histiocytic sarcoma of the lung. An overview of clinical features of the entity is presented in connection with our case report. Orv Heti. 2023; 164(34): 1350-1357.PMID:37634158 | DOI:10.1556/650.2023.32844 (Source: Orvosi Hetilap)
Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: Bal ázs Vincze Erika T óth Laura Iski P éter Mezei K ároly Szabó L ászló Országh Judit Kov ács Zolt án Szöllősi Éva Szövördi Imre T óth Source Type: research
Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo
In conclusion, we demonstrated that tazemetostat is a unique multispecific chemosensitizer, which has strong potential to overcome limitations seen in the era of traditional MDR modulators.PMID:37634597 | DOI:10.1016/j.bcp.2023.115769 (Source: Biochemical Pharmacology)
Source: Biochemical Pharmacology - August 27, 2023 Category: Drugs & Pharmacology Authors: Youssif Budagaga Ziba Sabet Yu Zhang Eva Novotn á Ivo Hanke Tom áš Rozkoš Jakub Hofman Source Type: research
Pulmonary histiocytic sarcoma
We report the case of a 52-year-old man with a tumor of central localization in the left lung. Pulmonectomy was performed. Histology verified histiocytic sarcoma of the lung. An overview of clinical features of the entity is presented in connection with our case report. Orv Heti. 2023; 164(34): 1350-1357.PMID:37634158 | DOI:10.1556/650.2023.32844 (Source: Orvosi Hetilap)
Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: Bal ázs Vincze Erika T óth Laura Iski P éter Mezei K ároly Szabó L ászló Országh Judit Kov ács Zolt án Szöllősi Éva Szövördi Imre T óth Source Type: research
Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo
In conclusion, we demonstrated that tazemetostat is a unique multispecific chemosensitizer, which has strong potential to overcome limitations seen in the era of traditional MDR modulators.PMID:37634597 | DOI:10.1016/j.bcp.2023.115769 (Source: Biochemical Pharmacology)
Source: Biochemical Pharmacology - August 27, 2023 Category: Drugs & Pharmacology Authors: Youssif Budagaga Ziba Sabet Yu Zhang Eva Novotn á Ivo Hanke Tom áš Rozkoš Jakub Hofman Source Type: research
Pulmonary histiocytic sarcoma
We report the case of a 52-year-old man with a tumor of central localization in the left lung. Pulmonectomy was performed. Histology verified histiocytic sarcoma of the lung. An overview of clinical features of the entity is presented in connection with our case report. Orv Heti. 2023; 164(34): 1350-1357.PMID:37634158 | DOI:10.1556/650.2023.32844 (Source: Orvosi Hetilap)
Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: Bal ázs Vincze Erika T óth Laura Iski P éter Mezei K ároly Szabó L ászló Országh Judit Kov ács Zolt án Szöllősi Éva Szövördi Imre T óth Source Type: research
Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo
In conclusion, we demonstrated that tazemetostat is a unique multispecific chemosensitizer, which has strong potential to overcome limitations seen in the era of traditional MDR modulators.PMID:37634597 | DOI:10.1016/j.bcp.2023.115769 (Source: Biochemical Pharmacology)
Source: Biochemical Pharmacology - August 27, 2023 Category: Drugs & Pharmacology Authors: Youssif Budagaga Ziba Sabet Yu Zhang Eva Novotn á Ivo Hanke Tom áš Rozkoš Jakub Hofman Source Type: research
Pulmonary histiocytic sarcoma
We report the case of a 52-year-old man with a tumor of central localization in the left lung. Pulmonectomy was performed. Histology verified histiocytic sarcoma of the lung. An overview of clinical features of the entity is presented in connection with our case report. Orv Heti. 2023; 164(34): 1350-1357.PMID:37634158 | DOI:10.1556/650.2023.32844 (Source: Orvosi Hetilap)
Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: Bal ázs Vincze Erika T óth Laura Iski P éter Mezei K ároly Szabó L ászló Országh Judit Kov ács Zolt án Szöllősi Éva Szövördi Imre T óth Source Type: research
Pulmonary histiocytic sarcoma
We report the case of a 52-year-old man with a tumor of central localization in the left lung. Pulmonectomy was performed. Histology verified histiocytic sarcoma of the lung. An overview of clinical features of the entity is presented in connection with our case report. Orv Heti. 2023; 164(34): 1350-1357.PMID:37634158 | DOI:10.1556/650.2023.32844 (Source: Orvosi Hetilap)
Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: Bal ázs Vincze Erika T óth Laura Iski P éter Mezei K ároly Szabó L ászló Országh Judit Kov ács Zolt án Szöllősi Éva Szövördi Imre T óth Source Type: research
Pulmonary histiocytic sarcoma
We report the case of a 52-year-old man with a tumor of central localization in the left lung. Pulmonectomy was performed. Histology verified histiocytic sarcoma of the lung. An overview of clinical features of the entity is presented in connection with our case report. Orv Heti. 2023; 164(34): 1350-1357.PMID:37634158 | DOI:10.1556/650.2023.32844 (Source: Orvosi Hetilap)
Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: Bal ázs Vincze Erika T óth Laura Iski P éter Mezei K ároly Szabó L ászló Országh Judit Kov ács Zolt án Szöllősi Éva Szövördi Imre T óth Source Type: research
